Ontology highlight
ABSTRACT:
SUBMITTER: Pan QZ
PROVIDER: S-EPMC4361845 | biostudies-other | 2015
REPOSITORIES: biostudies-other
Pan Qiu-Zhong QZ Wang Qi-Jing QJ Dan Jia-Qiang JQ Pan Ke K Li Yong-Qiang YQ Zhang Yao-Jun YJ Zhao Jing-Jing JJ Weng De-Sheng DS Tang Yan Y Huang Li-Xi LX He Jia J Chen Shi-Ping SP Ke Miao-La ML Chen Min-Shan MS Wicha Max S MS Chang Alfred E AE Zeng Yi-Xin YX Li Qiao Q Xia Jian-Chuan JC
Scientific reports 20150317
The benefits of adjuvant cytokine-induced killer (CIK) cell immunotherapy for hepatocellular carcinoma (HCC) remain mixed among patients. Here, we constructed a prognostic nomogram to enable individualized predictions of survival benefit of adjuvant CIK cell treatment for HCC patients. Survival analysis showed that the median overall survival (OS) and progression-free survival (PFS) for patients in the hepatectomy/CIK combination group were 41 and 16 months, respectively, compared to 28 and 12 m ...[more]